Thymoquinone reduces mouse colon tumor cell invasion and inhibits tumor growth in murine colon cancer models

We have shown that thymoquinone (TQ) is a potent antitumor agent in human colorectal cancer cells. In this study, we evaluated TQ's therapeutic potential in two different mice colon cancer models [ 1,2 ‐dimethyl hydrazine (DMH) and xenografts]. We also examined TQ effects on the growth of C26 mouse colorectal carcinoma spheroids and assessed tumor invasion in vitro. Mice were treated with saline, TQ, DMH, or combinations once per week for 30 weeks and the multiplicity, size and distribution of aberrant crypt foci (ACF) and tumors were determined at weeks 10, 20 and 30. TQ injected intraperitoneally (i.p.) significantly reduced the numbers and sizes of ACF at week 10; ACF numbers were reduced by 86%. Tumor multiplicity was reduced at week 20 from 17.8 in the DMH group to 4.2 in mice injected with TQ. This suppression was observed at week 30 and was long‐term; tumors did not re‐grow even when TQ injection was discontinued for 10 weeks. In a xenograft model of HCT116 colon cancer cells, TQ significantly (P < 0.05) delayed the growth of the tumor cells. Using a matrigel artificial basement membrane invasion assay, we demonstrated that sub‐cyto‐toxic doses of TQ (40μM) decreased C26 cell invasion by 50% and suppressed growth in three‐dimensional spheroids. Apoptotic signs seen morphologically were increased significantly in TQ‐treated spheroids. TUNEL staining of xenografts and immunostaining for caspase 3 cleavage in DMH tumors confirmed increased apoptosis in mouse tumors in response to TQ. These data should encourage further in vivo testing and support the potential use of TQ as a therapeutic agent in human colorectal cancer.

[1]  Steffen Zopf,et al.  Apoptosis, proliferation and differentiation patterns are influenced by Zebularine and SAHA in pancreatic cancer models , 2007, Scandinavian journal of gastroenterology.

[2]  D. Schuppan,et al.  Variants of bcl-2 specific siRNA for silencing antiapoptotic bcl-2 in pancreatic cancer , 2005, Gut.

[3]  A. Roessner,et al.  Interactions between human colon carcinoma cells, fibroblasts and monocytic cells in coculture--regulation of cathepsin B expression and invasiveness. , 2005, Cancer letters.

[4]  R. Schneider-Stock,et al.  Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism. , 2004, International journal of oncology.

[5]  S. Bent,et al.  Commonly used herbal medicines in the United States: a review. , 2004, The American journal of medicine.

[6]  Y. Surh,et al.  Cancer chemoprevention with dietary phytochemicals , 2003, Nature Reviews Cancer.

[7]  L. Schwartz,et al.  Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  B. Ali,et al.  Pharmacological and toxicological properties of Nigella sativa , 2003, Phytotherapy research : PTR.

[9]  S. Fukushima,et al.  Chemopreventive Potential of Volatile Oil From Black Cumin (Nigella sativa L.) Seeds Against Rat Colon Carcinogenesis , 2003, Nutrition and cancer.

[10]  O. Badary,et al.  Thymoquinone Is a Potent Superoxide Anion Scavenger , 2003, Drug and chemical toxicology.

[11]  A. El-Mahmoudy,et al.  Thymoquinone suppresses expression of inducible nitric oxide synthase in rat macrophages. , 2002, International immunopharmacology.

[12]  A. El‐Khatib,et al.  Effects of thymoquinone on antioxidant enzyme activities, lipid peroxidation and DT‐diaphorase in different tissues of mice: a possible mechanism of action , 2002, Cell biochemistry and function.

[13]  D. Parkin,et al.  Global cancer statistics in the year 2000. , 2001, The Lancet. Oncology.

[14]  A. Roessner,et al.  Cathepsin L antisense oligonucleotides in a human osteosarcoma cell line: Effects on the invasive phenotype , 2001, Cancer Gene Therapy.

[15]  H. Gali-Muhtasib,et al.  Plant Tannins Inhibit the Induction of Aberrant Crypt Foci and Colonic Tumors by 1,2-Dimethylhydrazine in Mice , 2001, Nutrition and cancer.

[16]  W. Mueller‐Klieser.  Tumor biology and experimental therapeutics. , 2000, Critical reviews in oncology/hematology.

[17]  P. Indovina,et al.  Apoptosis, cell adhesion and the extracellular matrix in the three-dimensional growth of multicellular tumor spheroids. , 2000, Critical reviews in oncology/hematology.

[18]  M. Mansour.  Protective effects of thymoquinone and desferrioxamine against hepatotoxicity of carbon tetrachloride in mice. , 2000, Life sciences.

[19]  R P Bird,et al.  The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. , 2000, Toxicology letters.

[20]  O. Badary.  Thymoquinone attenuates ifosfamide-induced Fanconi syndrome in rats and enhances its antitumor activity in mice. , 1999, Journal of ethnopharmacology.

[21]  O. Badary,et al.  Inhibition of benzo(a)pyrene-induced forestomach carcinogenesis in mice by thymoquinone. , 1999, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[22]  Junji Kato,et al.  Aberrant crypt foci of the colon as precursors of adenoma and cancer , 1998, The New England journal of medicine.

[23]  O. Badary,et al.  Thymoquinone protects against doxorubicin-induced cardiotoxicity without compromising its antitumor activity. , 1998, Journal of experimental & clinical cancer research : CR.

[24]  O. Badary,et al.  Acute and subchronic toxicity of thymoquinone in mice , 1998 .

[25]  P. Crooks,et al.  The in vitro anti-tumor activity of some crude and purified components of blackseed, Nigella sativa L. , 1998, Anticancer research.

[26]  O. Badary,et al.  Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity. , 1997, Canadian journal of physiology and pharmacology.

[27]  P. Cerutti.  Oxy-radicals and cancer , 1994, The Lancet.

[28]  A. El-Mahmoudy,et al.  Successful abrogation by thymoquinone against induction of diabetes mellitus with streptozotocin via nitric oxide inhibitory mechanism. , 2005, International immunopharmacology.

[29]  Felix I. Adah,et al.  Effects of sustained delivery of thymoqiunone on bone healing of male rats. , 2004, Biomedical sciences instrumentation.

[30]  H. Hosseinzadeh,et al.  Anticonvulsant effects of thymoquinone, the major constituent of Nigella sativa seeds, in mice. , 2004, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[31]  O. Al‐Shabanah,et al.  Effects of volatile oil constituents of Nigella sativa on carbon tetrachloride-induced hepatotoxicity in mice: evidence for antioxidant effects of thymoquinone. , 2001, Research communications in molecular pathology and pharmacology.

[32]  O. Badary,et al.  Inhibitory effects of thymoquinone against 20-methylcholanthrene-induced fibrosarcoma tumorigenesis. , 2001, Cancer detection and prevention.

[33]  M. Lipkin,et al.  Dietary factors in human colorectal cancer. , 1999, Annual review of nutrition.

[34]  R. Sutherland,et al.  Growth and cellular characteristics of multicell spheroids. , 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.